General Information of Drug Transporter (DT)
DT ID DTD0173 Transporter Info
Gene Name SLC25A15
Transporter Name Mitochondrial ornithine transporter 1
Gene ID
10166
UniProt ID
Q9Y619
Post-Translational Modification of This DT
Overview of SLC25A15 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Malonylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Malonylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A15 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

36

Experimental Method

Co-Immunoprecipitation

Detailed Description

Malonylation at SLC25A15 Lysine 36 has the potential to affect its expression or activity.

Oxidation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A15 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

23

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A15 Cystine 23 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A15 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

125

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A15 Cystine 125 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A15 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

159

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A15 Serine 159 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A15 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

196

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A15 Serine 196 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A15 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

142

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A15 Threonine 142 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A15 [7]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

100

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A15 Lysine 100 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A15 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

245

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A15 Lysine 245 has the potential to affect its expression or activity.
References
1 Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
4 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5 Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer. Cell. 2016 Aug 11;166(4):1041-1054.
6 The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics. 2011 Jan;10(1):M110.004457.
7 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
8 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
9 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.